Management of Glottic Incompetency

  • Vaninder K. Dhillon
  • Lee M. AkstEmail author


Glottic incompetency can lead to significant voice and swallow problems. The etiologies of glottic incompetency can be secondary to vocal fold paralysis or paresis or can be more progressive, as in Parkinson’s disease. Management of glottic incompetency relies not only on history, associated symptoms, and the size of the glottic gap but also on the assessment of patient goals and expectations and which treatment option is feasible. This chapter discusses the different modalities of treatment for glottic incompetency, the factors involved in the decision-making regarding an appropriate intervention, and the research that currently guide practice paradigms. The goal of this chapter is to organize the management of glottic incompetency for providers who work with these patients, supported by an evidence-based approach.


Glottic incompetency Injection laryngoplasty Medialization laryngoplasty Speech- language pathology 


  1. 1.
    Dursun G, Boynukalin S, Ozgursoy OB, Coruh I. Long-term results of different treatment modalities for glottic insufficiency. Am J Otolaryngol. 2008;29(1):7–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Vaca M, Cobeta I, Mora E, Reyes P. Clinical assessment of glottal insufficiency in age-related dysphonia. J Voice. 2017;31(1):128.e1–5.CrossRefGoogle Scholar
  3. 3.
    Reiter R, Hoffmann TK, Rotter N, Pickhard A, Scheithauer MO, Brosch S. Etiology, diagnosis, differential diagnosis and therapy of vocal fold paralysis. Laryngorhinootologie. 2014;93(3):161–73. [Article in German]PubMedGoogle Scholar
  4. 4.
    Badia PI, Hillel AT, Shah MD, Johns MM 3rd, Klein AM. Computed tomography has low yield in the evaluation of idiopathic unilateral true vocal fold paresis. Laryngoscope. 2013;123(1):204–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Paddle PM, Mansor MB, Song PC, Franco RA Jr. Diagnostic yield of computed tomography in the evaluation of idiopathic vocal fold paresis. Otolaryngol Head Neck Surg. 2015;153(3):414–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Chang JI, Bevans SE, Schwartz SR. Otolaryngology clinic of North America: evidence-based practice: management of hoarseness/dysphonia. Otolaryngol Clin North Am. 2012;45(5):1109–26.PubMedCrossRefGoogle Scholar
  7. 7.
    Stachler RJ, Francis DO, Schwartz SR, Damask CC, Digoy GP, Krouse HJ, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg. 2018;158(1 Suppl):S1–S42.PubMedCrossRefGoogle Scholar
  8. 8.
    Lagier A, Polle-Pelletier V, Giovanni A, Marie JP. Vocal fold medialization: which are the available fillers in France in 2010? Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(2):99–101.PubMedCrossRefGoogle Scholar
  9. 9.
    Rosen CA, Simpson B. Operative techniques in laryngology. Berlin, Heidelberg: Springer; 2008.Google Scholar
  10. 10.
    Chhetri DK, Jamal N. Percutaneous injection laryngoplasty. Laryngoscope. 2014;124(3):742–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Rosen CA, Gartner-Schmidt J, Casiano R, Anderson TD, Johnson F, Remacle M, et al. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report. Laryngoscope. 2009;119(5):1033–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Carroll TL, Rosen CA. Long-term results of calcium hydroxylapatite for vocal fold augmentation. Laryngoscope. 2011;121(2):313–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Cantarella G, Baracca G, Forti S, Gaffuri M, Mazzola RF. Outcomes of structural fat grafting for paralytic and non-paralytic dysphonia. Acta Otorhinolaryngol Ital. 2011;31(3):154–60.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Isshiki N, Morita H, Okamura H, Hiramoto M. Thyroplasty as a new phonosurgical technique. Acta Otolaryngol. 1974;78(5–6):451–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Zeitels SM, Mauri M, Dailey SH. Adduction arytenopexy for vocal fold paralysis: indications and technique. J Laryngol Otol. 2004;118(7):508–16.PubMedCrossRefGoogle Scholar
  16. 16.
    Sulica L, Blitzer A. Vocal fold paralysis. Berlin: Springer; 2006.CrossRefGoogle Scholar
  17. 17.
    Zeitels SM, Hochman I, Hillman RE. Adduction arytenopexy: a new procedure for paralytic dysphonia with implications for implant medialization. Ann Otol Rhinol Laryngol Suppl. 1998;173(9):2–24.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Lu FL, Casiano RR, Lundy DS, Xue JW. Vocal evaluation of thyroplasty type I in the treatment of nonparalytic glottic incompetence. Ann Otol Rhinol Laryngol. 1998;107(2):113–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Rosen CA, Statham MM. Vocal fold injection as treatment for glottic insufficiency: pro. Arch Otolaryngol Head Neck Surg. 2010;136(8):825.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Cohen S. Vocal fold injection as treatment for glottic insufficiency: con. Arch Otolaryngol Head Neck Surg. 2010;136(8):827–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Morgan JE, Zraick RI, Griffin AW, Bowen TL, Johnson FL. Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis. Laryngoscope. 2007;117(11):2068–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Hillel AT, Ochsner MC, Johns MM 3rd, Klein AM. A cost and time analysis of laryngology procedures in the endoscopy suite versus the operating room. Laryngoscope. 2016;126(6):1385–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Damrose EJ, Berke GS. Advances in the management of glottis insufficiency. Curr Opin Otolaryngol Head Neck Surg. 2003;11(6):480–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Bhattacharyya N, Batirel H, Swanson SJ. Improved outcomes with early vocal fold medialization for vocal fold paralysis after thoracic surgery. Auris Nasus Larynx. 2003;30(1):71–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Carroll TL, Rosen CA. Trial vocal fold injection. J Voice. 2010;24(4):494–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Chen DW, Price MD, LeMaire SA, Coselli JS, Liou NE, Ongkasuwan J. Early versus late inpatient awake transcervical injection laryngoplasty after thoracic aortic repair. Laryngoscope. 2018;128(1):144–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Friedman AD, Burns JA, Heaton JT, Zeitels SM. Early versus late injection medialization for unilateral vocal fold paralysis. Laryngoscope. 2010;120(10):2042–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Misono S, Merati AL. Evidence-based practice: evaluation and management of unilateral vocal fold paralysis. Otolaryngol Clin North Am. 2012;45(5):1083–108.PubMedCrossRefGoogle Scholar
  29. 29.
    Desuter G, Dedry M, Schaar B, van Lith-Bijl J, van Benthem PP, Sjögren EV. Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature. Eur Arch Otorhinolaryngol. 2018;275(2):459–68.PubMedCrossRefGoogle Scholar
  30. 30.
    Costello D. Change to earlier surgical interventions: contemporary management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2015;23(3):181–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Sulica L, Blitzer A. Vocal fold paresis: evidence and controversies. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):159–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Litts JK, Fink DS, Clary MS. The effect of vocal fold augmentation on cough symptoms in the presence of glottic insufficiency. Laryngoscope. 2018;128(6):1316–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Hartelius L, Svensson P. Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: a survey. Folia Phoniatr Logop. 1994;46(1):9–17.PubMedCrossRefGoogle Scholar
  34. 34.
    Berke GS, Gerratt B, Kreiman J, Jackson K. Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Laryngoscope. 1999;109(8):1295–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. 2004;25(2):169–80.PubMedCrossRefGoogle Scholar
  36. 36.
    Sackley CM, Smith CH, Rick C, Brady MC, Ives N, Patel R, et al. Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial. Trials. 2014;15:213.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Bauer V, Aleric Z, Jancic E. Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis. Int Arch Otorhinolaryngol. 2015;19(2):100–5.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Lalich IJ, Ekbom DC, Starkman SJ, Orbelo DM, Morgenthaler TI. Vocal fold motion impairment in multiple system atrophy. Laryngoscope. 2014;124(3):730–5.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Rusz J, Bonnet C, Klempíř J, Tykalová T, Baborová E, Novotný M, et al. Speech disorders reflect differing pathophysiology in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy. J Neurol. 2015;262(4):992–1001.PubMedCrossRefGoogle Scholar
  40. 40.
    Tomik J, Tomik B, Wiatr M, Składzień J, Stręk P, Szczudlik A. The evaluation of abnormal voice qualities in patients with ALS. Neurodegener Dis. 2015;15(4):225–32.PubMedCrossRefGoogle Scholar
  41. 41.
    Walton C, Conway E, Blackshaw H, Carding P. Unilateral vocal fold paralysis: a systematic review of speech-language pathology management. J Voice. 2017;31(4):509.e7–509.e22.CrossRefGoogle Scholar
  42. 42.
    El-Banna M, Youssef G. Early voice therapy in patients with unilateral vocal fold paralysis. Folia Phonatria Logop. 2014;66(6):237–43.CrossRefGoogle Scholar
  43. 43.
    Busto-Crespo O, Uzcanga-Lacabe M, Abad-Marco A, Berasategui I, García L, Maraví E, et al. Longitudinal voice outcomes after voice therapy in unilateral vocal fold paralysis. J Voice. 2016;30(6):767.e9–767.e15.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Otolaryngology–Head and Neck SurgeryJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations